NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
19/09/2025
Voltar para busca
Dado oficial do USPTO
ACCREDO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ACCREDO
ST13
US500000087871539Classe
9, 35, 41, 44
Pedido
87871539
Registro
5760777
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
20/09/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 41, 44
Data de depósito
10/04/2018
Data de registro
28/05/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
19/09/2025
Última transação
20/09/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Primeiro uso
2009-01-00
Primeiro uso no comércio
2009-01-00
Código do desenho
4
Tipo de titular
03
Localização do titular
St. Louis, MO
Examinador
HOPKINS II, DEAN
Localização atual
Historical data usage
Titulares e representantes
Titulares
Express Scripts Strategic Development, Inc.
Representantes
Troy E. Larson
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 41Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
resources appropriate for support of disease managementnamely downloadable electronic publications in the nature of brochuresbooklets and newsletters related to the support of disease management
Classe 35
mail order pharmacy services specializing in the treatment and control of chronic diseases and specialty medications; mail order pharmacy services specializing in the control of hemophilia
Classe 41
Providing patient educational servicesconducting programs in the field of chronic diseases and specialty medicationsdistributing course materials in connection therewith and providing patient educational servicesconducting programs in the field of proper product-reconstitution and administration; providing resources appropriate for support of disease managementproviding a website featuring non-downloadable publications in the nature of brochures and newsletters related to the support of disease management; providing a website featuring non-downloadable videos related to the support of disease management; educational services for product manufacturerspharmaceutical clinicians and biotech companiesclinicianscontract research organizations and insurance providersconducting classesone-on-one sessions and telephonic workshops in the field of clinical education and distributing course materials in connection therewith; educational servicesclassesone on one sessions and telephonic workshops which provide physiciansinsurance companies and patients with specific characteristics associated with disease management products; educational services and resourcesconducting workshops for children to help them understand hemophilia; educational servicesconducting workshops for children to help them understand hemophilia and other chronic conditions and diseases
Classe 44
Nursing care specializing in the treatmentprevention and control of chronic diseasesnursing care services related to specialty medications; nursing care specializing in the treatmentprevention and control of hemophilia; medical servicesadministration of pharmaceutical preparations used in the treatment of chronic diseases and administration of pharmaceutical preparations used in the treatment of hemophilia; administration of pharmaceutical preparations used in the treatment of chronic diseases; nursing and pharmacy care servicesdisease management services; telephone hotline counselingoffering healthcare advice; services consisting of providing nutritional guidance and consultation to chronically ill patients; providing educational information about nursing and pharmacy care servicesproviding resources appropriate for support of disease management
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
19/09/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
19/09/2025
E815
TEAS SECTION 8 & 15 RECEIVED
08/05/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
25/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/09/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
28/05/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/06/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/06/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
28/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/03/2019
PUBO
PUBLISHED FOR OPPOSITION
12/03/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/02/2019
ALIE
ASSIGNED TO LIE
01/02/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/01/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
17/01/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17/01/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
17/01/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
17/01/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/01/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/01/2019
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
15/01/2019
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/09/2018
GNFR
FINAL REFUSAL E-MAILED
04/09/2018
CNFR
FINAL REFUSAL WRITTEN
04/09/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/07/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/07/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/04/2018
GNRT
NON-FINAL ACTION E-MAILED
30/04/2018
CNRT
NON-FINAL ACTION WRITTEN
30/04/2018
DOCK
ASSIGNED TO EXAMINER
27/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/04/2018
NWAP
NEW APPLICATION ENTERED
13/04/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ACCREDO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.